• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福莫特罗是一种新型吸入性β2肾上腺素能激动剂,在抑制过度通气引起的支气管收缩方面,其作用时间比沙丁胺醇更长。

Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.

作者信息

Malo J L, Cartier A, Trudeau C, Ghezzo H, Gontovnick L

机构信息

Department of Chest Medicine, Hôpital du Sacré-Coeur, Montreal, Canada.

出版信息

Am Rev Respir Dis. 1990 Nov;142(5):1147-52. doi: 10.1164/ajrccm/142.5.1147.

DOI:10.1164/ajrccm/142.5.1147
PMID:1978619
Abstract

The duration of effect of inhaled formoterol (24 micrograms) was compared with that of a placebo and that of inhaled albuterol (200 micrograms) in 12 adult asthmatic subjects who underwent hyperventilation tests with cold dry air (-20 degrees C) on 4 study days. On the control day, they were subjected to four hyperventilation tests to ensure functional stability. On the 3 remaining days, after a first hyperventilation test, they inhaled placebo, albuterol, or formoterol in randomized, double-blind fashion. The hyperventilation test was repeated 1, 4, and 8 h and, if the blocking effect was still present, 12 and 24 h after the drug had been administered. The dose of hyperventilation of cold air causing a 20% fall in FEV1 (PD20) was interpolated on the dose-response curve. The magnitude of the blocking effect at each time interval on each study day was assessed by comparing the changes in PD20 from baseline with the within-day variability of PD20 (standardized change in PD20). The acute bronchodilator effect was not significantly different as assessed 15 min (21 +/- 14% for albuterol and 18 +/- 18% for formoterol) and 1 h (20 +/- 13% for albuterol and 18 +/- 17% for formoterol) after administering the medication. The duration of the blocking effect, defined as the return to 2 SD from the standardized change in PD20, was significantly more prolonged for formoterol (8.0 +/- 3.4 h) than for albuterol (3.0 +/- 1.7 h) (t = 4.2, p less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在12名成年哮喘患者中,比较了吸入福莫特罗(24微克)与安慰剂以及吸入沙丁胺醇(200微克)的作用持续时间。这12名患者在4个研究日接受了冷干空气(-20摄氏度)过度通气试验。在对照日,他们接受4次过度通气试验以确保功能稳定。在其余3天,在首次过度通气试验后,他们以随机、双盲方式吸入安慰剂、沙丁胺醇或福莫特罗。在给药后1、4和8小时重复进行过度通气试验,如果阻断作用仍然存在,则在12和24小时后重复。在剂量-反应曲线上推算出使第一秒用力呼气量(FEV1)下降20%的冷空气过度通气剂量(PD20)。通过比较PD20相对于基线的变化与PD20的日内变异性(PD20的标准化变化),评估每个研究日每个时间间隔的阻断作用大小。用药后15分钟(沙丁胺醇为21±14%,福莫特罗为18±18%)和1小时(沙丁胺醇为20±13%,福莫特罗为18±17%)时,评估的急性支气管扩张作用无显著差异。阻断作用的持续时间定义为从PD20的标准化变化恢复到2个标准差,福莫特罗(8.0±3.4小时)比沙丁胺醇(3.0±1.7小时)显著延长(t = 4.2,p<0.0001)。(摘要截断于250字)

相似文献

1
Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.福莫特罗是一种新型吸入性β2肾上腺素能激动剂,在抑制过度通气引起的支气管收缩方面,其作用时间比沙丁胺醇更长。
Am Rev Respir Dis. 1990 Nov;142(5):1147-52. doi: 10.1164/ajrccm/142.5.1147.
2
Duration of action of inhaled terbutaline at two different doses and of albuterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in asthmatic subjects.两种不同剂量吸入用特布他林及沙丁胺醇对哮喘患者在干冷空气过度通气诱发支气管收缩时的保护作用持续时间。
Am Rev Respir Dis. 1989 Sep;140(3):817-21. doi: 10.1164/ajrccm/140.3.817.
3
[Duration of bronchial protective effect of salmeterol in asthma induced by hyperventilation with dry cold air].[沙美特罗对干冷空气过度通气诱发哮喘的支气管保护作用持续时间]
Rev Mal Respir. 1992;9 Suppl 1:R19-21.
4
Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.沙美特罗,一种新型吸入性β2肾上腺素能激动剂,在抑制过度通气引起的支气管收缩方面比沙丁胺醇具有更长的阻滞作用。
J Allergy Clin Immunol. 1992 Feb;89(2):567-74. doi: 10.1016/0091-6749(92)90324-u.
5
Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.吸入性β2受体激动剂福莫特罗对乙酰甲胆碱诱发的支气管收缩具有持久的保护作用。
Am Rev Respir Dis. 1991 May;143(5 Pt 1):998-1001. doi: 10.1164/ajrccm/143.5_Pt_1.998.
6
Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.福莫特罗常规治疗稳定期哮喘患者后β2肾上腺素能受体调节及支气管扩张剂敏感性
J Allergy Clin Immunol. 1998 Mar;101(3):337-41. doi: 10.1016/S0091-6749(98)70245-3.
7
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.布地奈德/福莫特罗与福莫特罗、沙丁胺醇和安慰剂对比在哮喘患者中对吸入 AMP 重复激发的保护作用:一项随机、双盲、交叉研究。
Respir Res. 2010 May 28;11(1):66. doi: 10.1186/1465-9921-11-66.
8
A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects.吸入用沙丁胺醇与两种沙美特罗制剂对哮喘患者气道反应性的单剂量比较。
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):626-9. doi: 10.1164/ajrccm/144.3_Pt_1.626.
9
A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.高剂量沙丁胺醇不能克服接受常规沙美特罗或福莫特罗的哮喘患者的支气管保护亚敏感性。
J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):88-92. doi: 10.1016/s0091-6749(99)70530-0.
10
Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.吸入用福莫特罗预防哮喘儿童运动诱发性支气管收缩
Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):935-9. doi: 10.1164/ajrccm.149.4.7908246.

引用本文的文献

1
Regular treatment with formoterol for chronic asthma: serious adverse events.福莫特罗用于慢性哮喘的常规治疗:严重不良事件
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD006923. doi: 10.1002/14651858.CD006923.pub3.
2
Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.健康志愿者单次和多次使用福莫特罗或沙丁胺醇后的低钾血症。
Clin Drug Investig. 1998;15(6):523-9. doi: 10.2165/00044011-199815060-00009.
3
Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
福莫特罗。其药理特性及在哮喘治疗中疗效的最新进展
Drugs. 1998 Feb;55(2):303-22. doi: 10.2165/00003495-199855020-00016.
4
Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.沙美特罗、福莫特罗和沙丁胺醇对豚鼠离体气管的作用:最大舒张效应和效价存在差异,但功能拮抗作用无差异。
Thorax. 1993 May;48(5):547-53. doi: 10.1136/thx.48.5.547.
5
Long- versus short-acting beta 2-agonists. Implications for drug therapy.长效与短效β2受体激动剂。对药物治疗的影响。
Drugs. 1994 Feb;47(2):207-22. doi: 10.2165/00003495-199447020-00001.
6
Perioperative management of the asthmatic patient.哮喘患者的围手术期管理
Can J Anaesth. 1991 May;38(4 Pt 2):R26-38. doi: 10.1007/BF03008432.
7
Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.福莫特罗。其药理学特性及在可逆性阻塞性气道疾病中的治疗潜力综述。
Drugs. 1991 Jul;42(1):115-37. doi: 10.2165/00003495-199142010-00007.
8
Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.福莫特罗和沙丁胺醇可抑制豚鼠体内缓激肽和组胺诱导的气道微血管渗漏。
Br J Pharmacol. 1992 Apr;105(4):792-8. doi: 10.1111/j.1476-5381.1992.tb09059.x.